mesenchymal cell

(redirected from Mesenchymal stem cell)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Acronyms, Wikipedia.

mesenchymal cell

[¦mez·ən¦kī·məl ‚sel]
(histology)
An undifferentiated cell found in mesenchyme and capable of differentiating into various specialized connective tissues.
References in periodicals archive ?
Adipose differentiation of bone marrow-derived mesenchymal stem cells using Pluronic F-127 hydrogel in vitro.
Suppression of genes related to hypertrophy and osteogenesis in committed human mesenchymal stem cells cultured on novel nitrogen-rich plasma polymer coatings.
Table 1: Animal grouping and treatment protocol Noof SI Group animals Treatment 1 A 9 Control (standard dressing material with dermafin) (fig 3) 2 B 9 Xenogenic mesenchymal stem cell (rMSCs) injected around wound margin on day 0 (fig.
Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma.
Baltimore, MD; 410-522-5005) announced that the United States Patent and Trademark Office has issued United States Patent 5,855,619, claiming an implant composed of mesenchymal stem cells in a gel matrix that has contracted under tension.
Assessment of cytotoxicity of pure Imidazole using bone marrow mesenchymal stem cells
Mesenchymal stem cells are multipotential cells capable of proliferation and differentiation into osteogenic, chondrogenic and adipogenic lineages both in vitro and in vivo (2, 3).
Overview: Analysis of global grant activity, scientific publication rates, and patent applications reveal that research activity involving mesenchymal stem cells increased 58% year-over-year from 2008 to 2009, and 112% from 2009 to 2010.
It has been demonstrated that Wharton's jelly-derived mesenchymal stem cells (WJMSCs), a primitive stromal population, could integrate into ischemic cardiac tissues and significantly improve heart function.
Stemedica International has an exclusive license to manufacture and distribute the parent company's allogeneic, ischemia-tolerant mesenchymal stem cell (itMSC) and ischemia-tolerant neural stem cell (itNSC) lines and stem cell factors for Alzheimer's disease and vascular dementia indications.
The company says studies have shown that the type of stem cell used in Prochymal, the mesenchymal stem cell or MSC, can specifically target areas of inflammation.